Minireviews
Copyright ©The Author(s) 2023.
World J Orthop. Jul 18, 2023; 14(7): 505-515
Published online Jul 18, 2023. doi: 10.5312/wjo.v14.i7.505
Table 1 Single or double-arms trials assessing effectiveness of platelet-rich plasma vs placebo injections, dry needling, or exercise
Ref.
Level of evidence
Design
Groups (n)
Injections/dosis
Outcomes measure
Follow-up
Conclusions
Kesikburun et al[54], 2013IUltrasound-guided PRP injections vs saline injections40 patients PRP (20), placebo (20)1/5 mLVAS, WORC, and SPADI3, 6, 12, 24 wk. 1 yrPRP is not more effective in improving shoulder quality of life, pain, disability, and range of motion than placebo
Rha et al[57], 2013IPRP injections vs dry needling39 patients. PRP (20), dry needling (20)1/3 mLSPADI, passive ROM, global rating scale, ultrasound measurement24 wkPRP leads to a progressive reduction in pain and disability compared to dry needling
Scarpone et al[59], 2013IIIUltrasound guided PRP injection at the lesion and surrounding tendon181/3.5 mLMRI, VAS and three-item patient satisfaction scale8, 12, 52 wkImprovement in MRI, pain and function with PRP
Lee et al[62], 2019IIIPRP injection vs exercise treatment; leukocyte-poor vs leukocyte-rich PRP60. PRP (27), exercise (33)1/1.5 mLASES, CMS, and NRS12 wk, 24 wkPRP is more effective than exercise therapy for the first 3 mo
Kim et al[55], 2019IIPRP injection vs exercise treatment30 patients. PRP (15), exercise (15)1/2 mLASES, CMS, and NRS12 wk, 24 wkPRP had an advantage over exercise; improvement until 12 wk, slight decrease at 24 wk
Rossi et al[71], 2021IISubacromial PRP injections50 patients1/5 mLASES, CMS, and VAS1 yrPRP decreased pain, improved functional outcomes, and resolved sleep disturbances. Return to sports for most athletes
Oudelaar et al[77], 2021INACD + PRP vs NACD + CI88 patients. NACD + PRP (41), NACD + CI (47)1/5 mLVAS, CMS, DASH, OSS, EQ-5D6 wk, 3 mo, 6 mo, 12 mo, 24 moNACD + PRP was worse at the 6-wk follow-up but better at the 6-mo follow-up. Comparable results at 12 and 24 mo